Clinical Trial Update: Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating intense pulsed light as an adjunct to bromonidine for rosacea was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Bromonidine (bromonidine)
• Intense Pulsed Light

Snippet

Sponsor: Rabin Medical Center | Conditions: Rosacea | Phase 4 | Status: WITHDRAWN